<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hauspurg A</submitter><funding>NICHD NIH HHS</funding><funding>NCATS NIH HHS</funding><funding>NHLBI NIH HHS</funding><pagination>268-276</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8771430</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>7(3)</volume><pubmed_abstract>&lt;h4>Importance&lt;/h4>Hypertensive disorders of pregnancy are associated with future cardiovascular disease, perhaps because of subclinical cardiac dysfunction before pregnancy leading to impaired adaptation to pregnancy. Natriuretic peptides are promising biomarkers for detecting subclinical cardiac dysfunction outside of pregnancy.&lt;h4>Objective&lt;/h4>To investigate whether higher concentrations of N-terminal pro-brain natriuretic peptide (NT-proBNP) in early pregnancy would be associated with hypertensive disorders of pregnancy and hypertension 2 to 7 years post partum.&lt;h4>Design, setting, and participants&lt;/h4>This cohort study used data from the The Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-Be Heart Health Study, a prospective multicenter observational study. A total of 410</pubmed_abstract><journal>JAMA cardiology</journal><pubmed_title>Association of N-Terminal Pro-Brain Natriuretic Peptide Concentration in Early Pregnancy With Development of Hypertensive Disorders of Pregnancy and Future Hypertension.</pubmed_title><pmcid>PMC8771430</pmcid><funding_grant_id>U10 HL120018</funding_grant_id><funding_grant_id>UL1 TR000153</funding_grant_id><funding_grant_id>U10 HL120019</funding_grant_id><funding_grant_id>U10 HD063020</funding_grant_id><funding_grant_id>K12 HD043441</funding_grant_id><funding_grant_id>U10 HD063041</funding_grant_id><funding_grant_id>U10 HD063048</funding_grant_id><funding_grant_id>U10 HD063047</funding_grant_id><funding_grant_id>U10 HD063046</funding_grant_id><funding_grant_id>UL1 TR001881</funding_grant_id><funding_grant_id>U01 HL145358</funding_grant_id><funding_grant_id>U10 HL120034</funding_grant_id><funding_grant_id>UL1 TR000439</funding_grant_id><funding_grant_id>UL1 TR001108</funding_grant_id><funding_grant_id>U10 HL119989</funding_grant_id><funding_grant_id>U10 HD063053</funding_grant_id><funding_grant_id>U10 HD063037</funding_grant_id><funding_grant_id>U10 HL119993</funding_grant_id><funding_grant_id>U10 HD063036</funding_grant_id><funding_grant_id>UL1 TR000124</funding_grant_id><funding_grant_id>U10 HL119991</funding_grant_id><funding_grant_id>U10 HL119992</funding_grant_id><funding_grant_id>UL1 TR002548</funding_grant_id><funding_grant_id>U10 HL119990</funding_grant_id><funding_grant_id>U10 HD063072</funding_grant_id><funding_grant_id>U10 HL120006</funding_grant_id><pubmed_authors>Williams M</pubmed_authors><pubmed_authors>Yetukuri V</pubmed_authors><pubmed_authors>Williams CN</pubmed_authors><pubmed_authors>Hunter S</pubmed_authors><pubmed_authors>Zee PC</pubmed_authors><pubmed_authors>Davis M</pubmed_authors><pubmed_authors>Winters A</pubmed_authors><pubmed_authors>Mobley D</pubmed_authors><pubmed_authors>Pham V</pubmed_authors><pubmed_authors>Basner RC</pubmed_authors><pubmed_authors>Iams J</pubmed_authors><pubmed_authors>Perkins E</pubmed_authors><pubmed_authors>Wapner R</pubmed_authors><pubmed_authors>Peters M</pubmed_authors><pubmed_authors>Latimer C</pubmed_authors><pubmed_authors>Morby V</pubmed_authors><pubmed_authors>Alexander BV</pubmed_authors><pubmed_authors>Rouse CE</pubmed_authors><pubmed_authors>Foroud T</pubmed_authors><pubmed_authors>Pemberton VL</pubmed_authors><pubmed_authors>Lynch S</pubmed_authors><pubmed_authors>Daftary AR</pubmed_authors><pubmed_authors>Koch MA</pubmed_authors><pubmed_authors>Barnes S</pubmed_authors><pubmed_authors>Chung JH</pubmed_authors><pubmed_authors>Holder TE</pubmed_authors><pubmed_authors>Redline S</pubmed_authors><pubmed_authors>Marsh DJ</pubmed_authors><pubmed_authors>Shepard JS</pubmed_authors><pubmed_authors>Nhan-Chang CL</pubmed_authors><pubmed_authors>Araujo B</pubmed_authors><pubmed_authors>McFadden DW</pubmed_authors><pubmed_authors>Polito L</pubmed_authors><pubmed_authors>Wing DA</pubmed_authors><pubmed_authors>DeCain MJ</pubmed_authors><pubmed_authors>Hameed A</pubmed_authors><pubmed_authors>Franklin H</pubmed_authors><pubmed_authors>McNeil RB</pubmed_authors><pubmed_authors>Porto M</pubmed_authors><pubmed_authors>Greenland P</pubmed_authors><pubmed_authors>Silver RM</pubmed_authors><pubmed_authors>Levine LD</pubmed_authors><pubmed_authors>Straub AC</pubmed_authors><pubmed_authors>Grobman WA</pubmed_authors><pubmed_authors>Catov JM</pubmed_authors><pubmed_authors>Onativia A</pubmed_authors><pubmed_authors>Parry S</pubmed_authors><pubmed_authors>Surovec S</pubmed_authors><pubmed_authors>Peaceman AM</pubmed_authors><pubmed_authors>Schubert FP</pubmed_authors><pubmed_authors>Pien G</pubmed_authors><pubmed_authors>Dalton W</pubmed_authors><pubmed_authors>Emery SP</pubmed_authors><pubmed_authors>Louis JM</pubmed_authors><pubmed_authors>Torres C</pubmed_authors><pubmed_authors>Hoffman MK</pubmed_authors><pubmed_authors>Caritis SN</pubmed_authors><pubmed_authors>Bickus M</pubmed_authors><pubmed_authors>DiVito M</pubmed_authors><pubmed_authors>Meadows L</pubmed_authors><pubmed_authors>Reddy UM</pubmed_authors><pubmed_authors>Vorwaller K</pubmed_authors><pubmed_authors>Hauspurg A</pubmed_authors><pubmed_authors>Laposky A</pubmed_authors><pubmed_authors>Nageotte MP</pubmed_authors><pubmed_authors>Saade GR</pubmed_authors><pubmed_authors>NICHD nuMoM2b and NHLBI nuMoM2b Heart Health Study Networks</pubmed_authors><pubmed_authors>Speer PD</pubmed_authors><pubmed_authors>Ulanski J</pubmed_authors><pubmed_authors>Wadhwa PD</pubmed_authors><pubmed_authors>Campbell P</pubmed_authors><pubmed_authors>Haas DM</pubmed_authors><pubmed_authors>Ludmir J</pubmed_authors><pubmed_authors>Esplin MS</pubmed_authors><pubmed_authors>Bairey Merz CN</pubmed_authors><pubmed_authors>Mercer BM</pubmed_authors><pubmed_authors>Elovitz M</pubmed_authors><pubmed_authors>Fuchs K</pubmed_authors><pubmed_authors>Facco FL</pubmed_authors><pubmed_authors>McCormick CL</pubmed_authors><pubmed_authors>Chen YI</pubmed_authors><pubmed_authors>Rumney PJ</pubmed_authors><pubmed_authors>Postma J</pubmed_authors><pubmed_authors>Griggs C</pubmed_authors><pubmed_authors>Simhan HN</pubmed_authors><pubmed_authors>Parker CB</pubmed_authors><pubmed_authors>Willinger M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Association of N-Terminal Pro-Brain Natriuretic Peptide Concentration in Early Pregnancy With Development of Hypertensive Disorders of Pregnancy and Future Hypertension.</name><description>&lt;h4>Importance&lt;/h4>Hypertensive disorders of pregnancy are associated with future cardiovascular disease, perhaps because of subclinical cardiac dysfunction before pregnancy leading to impaired adaptation to pregnancy. Natriuretic peptides are promising biomarkers for detecting subclinical cardiac dysfunction outside of pregnancy.&lt;h4>Objective&lt;/h4>To investigate whether higher concentrations of N-terminal pro-brain natriuretic peptide (NT-proBNP) in early pregnancy would be associated with hypertensive disorders of pregnancy and hypertension 2 to 7 years post partum.&lt;h4>Design, setting, and participants&lt;/h4>This cohort study used data from the The Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-Be Heart Health Study, a prospective multicenter observational study. A total of 410</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Mar</publication><modification>2026-05-08T02:04:23.459Z</modification><creation>2024-11-15T20:05:48.929Z</creation></dates><accession>S-EPMC8771430</accession><cross_references><pubmed>35044418</pubmed><doi>10.1001/jamacardio.2021.5617</doi></cross_references></HashMap>